BSECompany Update2d ago · 27 Jul 2026, 02:26 pm
Please find attached herewith intimation for Analyst / Investor Meet.
Alkem Laboratories Ltd · 539523
✦ AI SummaryResults
Alkem Laboratories Ltd. invites investors and analysts for a conference call on August 14, 2026, to discuss its Q1FY27 financial results.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
97af6d3c-4d91-4120-a4b5-f8075080686c.pdf
View document text
27th July, 2026
The Corporate Relationship Department National Stock Exchange of India Limited
BSE Limited Exchange Plaza,
Phiroze Jeejeebhoy Towers, Bandra Kurla Complex,
Dalal Street, Bandra East,
Mumbai 400 001. Mumbai 400 051.
Scrip Code: 539523 Scrip Symbol: ALKEM
Sub: Intimation of Conference Call on Q1FY27
Dear Sir(s) / Madam,
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the
Q1FY27 financial results will be held on Friday, 14th August, 2026 at 04.30 p.m.
Please find attached herewith the conference call details.
Kindly take note of the same.
Sincerely,
For Alkem Laboratories Limited
Divya Mewani
Vice President – Legal & Deputy Company Secretary
Invite for Q1FY27 Conference Call at 4.30 pm IST, August 14, 2026
Mumbai, July 27, 2026: Alkem Laboratories Ltd. (NSE: ALKEM, BSE: 539523, Bloomberg:
ALKEM.IN, Reuters: ALKE.NS) will hold a conference call for investors and analysts on Friday,
August 14, 2026, from 4:30 pm to 5:30 pm IST to discuss its Q1FY27 financial results. The call
will follow the announcement of the Company’s Q1FY27 financial results on Friday, August 14,
2026.
Alkem Laboratories Ltd. will be represented on the call by:
Mr. Sandeep Singh - MD
Mr. Nitin Agrawal – CFO
Motilal Oswal Securities Ltd. will host the call.
Details of the conference call are as follows
Time 4:30 pm IST (GMT + 5:30) on Friday, August 14, 2026.
Dial in Details
India +91 22 6280 1149 / +91 22 7115 8050
International Toll-Free
USA 1 866 746 2133 UK 0 808 101 1573
Singapore 800 101 2045 Hong Kong 800 964 448
Express Join with Diamond Pass
https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=6179
880&linkSecurityString=34f8c9ec58
You are requested to dial in 10 minutes ahead of the scheduled start time.
Purvi Shah / Isha Trivedi Tushar Manudhane
Investor Relations / Media Institutional Research Analyst - Healthcare
Alkem Laboratories Ltd. Motilal Oswal Securities Ltd.
Mobile: +91 84337 00890 / 98925 90003 Tel.: +91 22 6129 1536 / +91 82911 38039
Tel.: +91 22 3982 9999 Ext: 9447 E-mail: Tushar.Manudhane@motilaloswal.com
E-mail: purvi.shah@alkem.com/
isha.trivedi@alkem.com